Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials
for Dermatitis Atopic
Drug: Amlitelimab
96 locations incl. Birmingham
Sponsor: Sanofi
Sex: All·Age: 12+
Code: NCT05492578·Phase 2, Phase 3·Enrolling By Invitation